- Presentations
- 3
- Markets
- 1
Crysvita is a brand of Burosumab marketed by Kyowa Kirin, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Burosumab
- Brand owner
- Kyowa Kirin
- Registered in
- United States
- Strengths and forms
- 10 mg/1 mL injection, 20 mg/1 mL injection, 30 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Crysvita 10 mg/1 mL injectionSubcutaneous Cold chain | Kyowa Kirin | US FDA | Available on request |
| Crysvita 20 mg/1 mL injectionSubcutaneous Cold chain | Kyowa Kirin | US FDA | Available on request |
| Crysvita 30 mg/1 mL injectionSubcutaneous Cold chain | Kyowa Kirin | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Crysvita
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.